Clinical trial
Prevalence and Prognostic Impact of Epigenetic MMRd in Endometrial Carcinomas
NCT05334303 is registered in ClinicalTrials.gov with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence and Prognostic Impact of Epigenetic MMRd in Endometrial Carcinomas
- Lead sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 17, 2022
- Completion date
- May 1, 2024
- Enrollment
- 400 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.